The introduction of Fountain Life’s Zori A was featured in a Longevity.Technology article. 

Fountain Life continues to lead the charge in revolutionizing healthcare, and under the leadership of CEO and co-founder Dr. Bill Kapp, the company has once again raised the bar with the launch of Zori AI — a groundbreaking generative AI platform purpose-built for functional and longevity medicine. 

As highlighted in Longevity.Technology, this innovation puts truly personalized, preventative care into the hands of both clinicians and patients. Zori AI synthesizes Fountain Life’s rich, proprietary diagnostic data — including full-body MRIs, genomic sequencing, and metabolic panels — to deliver precise, actionable insights that empower individuals to take control of their health like never before. 

Dr. Kapp's vision is bold and clear: replace symptom-chasing with root-cause analysis, and shift healthcare from reactive treatment to proactive optimization. With the acquisition of LifeOmic, a robust precision medicine platform, and the ability to train AI models in a private, secure cloud, Fountain Life now delivers a uniquely powerful, HIPAA-compliant health intelligence system. 

Through Dr. Kapp’s leadership, the company isn’t just predicting the future of medicine — it’s building it, one data-driven insight at a time.

Read the full article here.